ライフサイエンスコーパス: sleeve

1 or placebo sleeve (standard cotton/elastane sleeve).

2 inant gloved hand and from the surgical gown sleeve.

3 nd 12 collection fibers integrated in a 1 mm sleeve.

4 h vessels were embedded in a shared collagen sleeve.

5 ia-pause triggers rapid firing within the PV sleeve.

6 be a definitive trial of the heat-retaining sleeve.

7 d to a matrix reservoir through a connection sleeve.

8 deposition capillary via another connection sleeve.

9 ency in hemodialysis catheters with a fibrin sleeve.

10 terenol-induced automaticity elicited in SVC sleeves.

11 ic stimuli originating in the pulmonary vein sleeves.

12 ociated pericytes and empty type IV collagen sleeves.

13 cytoplasm along the endocardium of PV muscle sleeves.

14 xtent in the form of empty basement membrane sleeves.

15 aded as a result of the presence of coupling sleeves.

16 the majority of catheters occluded by fibrin sleeves.

17 n sleeve gastrectomy than in gastric bypass (sleeve 0.6%, bypass 0.4%, P = 0.009).

18 bypass 15.6%, P < 0.001) and complications (sleeve 6.6%, bypass 9.6%, P = 0.001), and lower overall

19 eeve gastrectomy had fewer re-interventions (sleeve 9.9%, bypass 15.6%, P < 0.001) and complications

20 ce of significantly more cylindrical scales (sleeves), a higher Marx line score, and a lower quality

21 This connection sleeve also acts as a mixing chamber, allowing the CEC e

22 Magnetic Erythrocyte Separator (H.E.R.M.E.S) sleeve, an apparatus that uses a magnetic bead-based sep

23 Expenditures were $38,632 after sleeve and $39,270 after bypass (P = .60).

24 Cumulative expenditures were $46,277 after sleeve and $48,211 after bypass (P = .22).

25 We compared all outcomes between sleeve and bypass for each entitlement group at 30 days,

26 mprises two copper sheets, integrated into a sleeve and connected to a coil, which form a resonant ci

27 D and DAD)-induced triggered activity in SVC sleeves and compares SVC and PV sleeve electrophysiologi

28 Activity in sleeves and homogenates proves to be the same when measu

29 We report on the synthesis of three new sleeves and their incorporation in OSK rods.

30 ndoscopic restrictive procedures, intestinal sleeves, and intragastric balloons have demonstrated sho

31 Pulmonary vein myocardial sleeves appear to provide a favorable substrate for re-e

32 Kenyon cells supplying axons to the sleeve are suggestive of class III Kenyon cell morpholog

33 The structures of these sleeves are based on neo-inositol, terephthalaldehyde di

34 ented by x-ray (cathetergram) to have fibrin sleeves at the catheter tips.

35 delivery of 7-hexanoyltaxol through polymer sleeves augments conventional mechanical treatment of at

36 Complex fiber orientations in the PV muscle sleeves away from the PV-LA junction were responsible fo

37 Sleeve axons bifurcate to provide a second pair of divis

38 As was shown years ago, a "sleeve"-based, chromosome-associated structure could, in

39 comparison, subjects who received the verum sleeve but believed they had received the placebo sleeve

40 s of the Dam1 ring differ from those of the "sleeve," but whether these differences are significant h

41 Manometry was performed by using a sleeve catheter passed through 1 nostril.

42 educed pericytes and empty basement membrane sleeves, caused widespread intratumoral hypoxia and tumo

43 A sleeve creating a cone of protective carbon dioxide gas

44 ularity decreased 38%, and basement membrane sleeves decreased 21% over 28 days.

45 asibility studies with a stent-based polymer sleeve delivering 7-hexanoyltaxol.

46 The sleeve demonstration shows the potential of the SCARS te

47 transport, including use of a gas-directing sleeve device.

48 Compared with PV, SVC sleeves display phase 4 depolarization, smaller V(max),

49 ned this hypothesis in canine pulmonary vein sleeves during interventions further shortening the acti

50 ivity in SVC sleeves and compares SVC and PV sleeve electrophysiological properties.

51 lt 25-gauge cannulas and 270-silicone watzke sleeves, enabling these instruments to be used in pediat

52 that is applied using a disposable, plastic sleeve encasement.

53 e but believed they had received the placebo sleeve exhibited only a marginally significant improveme

54 ite the apparent lack of an open cytoplasmic sleeve, forcing the reassessment of the mechanisms that

55 ing staplers buttressed with paired alginate sleeves (FOREseal).

56 al fibrillation (AF) is to isolate PV muscle sleeves from the LA.

57 coefficient of variation of Vmax is 16% for sleeves from the same mouse and 8% for mean values from

58 ong surgeons who over-rated their skill with sleeve gastrectomy (0.65 vs 0.27, p = 0.0181).

59 dence interval [CI], 3.2%-4.0%), followed by sleeve gastrectomy (2.2%; 95% CI, 1.2%-3.2%), and laparo

60 astric bypass (80-90 min operative time) and sleeve gastrectomy (30-45 min operative time), which, to

61 banding (n=1053), gastric bypass (795), and sleeve gastrectomy (317), with two procedures undefined.

62 Gastric bypass (6.56 kg/mo) and sleeve gastrectomy (6.29 kg/mo) were associated with gre

63 ux-en-Y gastric bypass (161 participants) or sleeve gastrectomy (67) were included in the analysis.

64 ed RR, 43.1; 95% CI, 19.7-94.5), followed by sleeve gastrectomy (adjusted RR, 16.6; 95% CI, 4.7-58.4)

65 ademic setting: common channel 75 to 125 cm, sleeve gastrectomy (approximately 100 mL gastric pouch),

66 of this study was to compare silicone-banded sleeve gastrectomy (BSG) to nonbanded sleeve gastrectomy

67 ], 1.70; 95% CI, 1.20-2.41; P = .003) and vs sleeve gastrectomy (HR, 1.98; 95% CI, 1.55-2.53; P < .00

68 safety of revisional surgery to laparoscopic sleeve gastrectomy (LSG) compared to laparoscopic Roux-Y

69 Laparoscopic sleeve gastrectomy (LSG) has been proposed as an effecti

70 long-term metabolic effects of laparoscopic sleeve gastrectomy (LSG) in patients with type 2 diabete

71 urgical techniques to use for a laparoscopic sleeve gastrectomy (LSG) including the use of staple lin

72 Laparoscopic sleeve gastrectomy (LSG) increases transplant eligibilit

73 Laparoscopic sleeve gastrectomy (LSG) is a promising procedure for ad

74 The prevalence of laparoscopic sleeve gastrectomy (LSG) is increasing, but data on its

75 Laparoscopic sleeve gastrectomy (LSG) is performed almost as often in

76 f diabetes who underwent either laparoscopic sleeve gastrectomy (LSG) or laparoscopic adjustable gast

77 jects before and 3 months after laparoscopic sleeve gastrectomy (LSG).

78 s index) patients who underwent laparoscopic sleeve gastrectomy (LSG).

79 to identify operative steps in laparoscopic sleeve gastrectomy (LSG).

80 -60] years; 1294 men [69.8%]), 4211 received sleeve gastrectomy (median [IQR] age, 52 [44-59] years;

81 Roux-en-Y gastric bypass (n = 161), sleeve gastrectomy (n = 67), or laparoscopic adjustable

82 hics were similar between RYGB (n = 673) and sleeve gastrectomy (n = 673) cohorts.

83 n = 16), morbidly obese patients who had had sleeve gastrectomy (n = 8), and nonobese patients (n = 1

84 andomly assigned to gastric bypass (n=54) or sleeve gastrectomy (n=55).

85 open gastric bypass (OR 3.51, CI 2.38-5.22); sleeve gastrectomy (OR 2.46, CI 1.73-3.50).

86 gastric bypass (OR 3.97, CI 1.77-8.91); and sleeve gastrectomy (OR 3.50, CI 1.30-9.34).

87 Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) account for >95% of bariatric pr

88 The objective was to study the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RY

89 Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RY

90 submitted a video of a typical laparoscopic sleeve gastrectomy (SG) between 2015-2016.

91 Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG) have been associated with a high

92 tcome of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) in Sweden, Norway, and the Nethe

93 Laparoscopic sleeve gastrectomy (SG) is an upcoming procedure in bari

94 Although sleeve gastrectomy (SG) is growing in favor, some random

95 ss technically challenging procedure such as sleeve gastrectomy (SG) is unknown.

96 banded sleeve gastrectomy (BSG) to nonbanded sleeve gastrectomy (SG) regarding weight loss, obesity-r

97 phagitis, and Barrett's esophagus (BE) after sleeve gastrectomy (SG) through a systematic review and

98 of the study was to compare the influence of sleeve gastrectomy (SG) versus Roux-en-Y gastric bypass

99 ent of glucose tolerance commonly seen after sleeve gastrectomy (SG), several observations challenge

100 t RYGB, adjustable gastric banding (AGB), or sleeve gastrectomy (SG).

101 isms associated with reflux events following sleeve gastrectomy (SG).

102 stric band (AGB) to gastric bypass (RYGB) or sleeve gastrectomy (SG).

103 igher rate of insulin cessation (71.7%) than sleeve gastrectomy (SG; 64.5%; RR 0.92, confidence inter

104 assigned (1:1) to receive gastric bypass or sleeve gastrectomy (the Oseberg study).

105 s) and 11 of 47 patients (23%) who underwent sleeve gastrectomy (unadjusted P=0.03, adjusted P=0.07,

106 compare diabetes outcomes following vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (R

107 al insurance claims data to compare vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (R

108 d to mediate part of the effects of vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass su

109 Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) and to identify potential taste

110 In a mouse model, vertical sleeve gastrectomy (VSG) caused trabecular and cortical

111 Vertical sleeve gastrectomy (VSG) has recently surpassed gastric

112 Vertical sleeve gastrectomy (VSG) involves the resection of ~ 80%

113 Vertical sleeve gastrectomy (VSG) is an effective therapeutic app

114 d whether the beneficial effects of vertical sleeve gastrectomy (VSG) on plasma lipid levels are weig

115 nditions of restricted weight gain: vertical sleeve gastrectomy (VSG) or food restriction.

116 Vertical sleeve gastrectomy (VSG) produces dramatic, sustained we

117 Vertical sleeve gastrectomy (VSG) produces sustainable weight los

118 Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) reduce weight and improve gluco

119 Roux-en-Y-Gastric Bypass (RYGB) and Vertical Sleeve Gastrectomy (VSG) surgery and that these changes

120 test this hypothesis, we performed vertical sleeve gastrectomy (VSG), a surgery with clinical effica

121 ome bariatric procedures, including vertical sleeve gastrectomy (VSG), and has been widely hypothesiz

122 iatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effect

123 Roux-en-Y gastric bypass (RYGB) or vertical sleeve gastrectomy (VSG), are the most effective approac

124 y, Roux-en-Y gastric bypass (RYGB), vertical sleeve gastrectomy (VSG), oral glucose administration, a

125 ents, and diet preference following vertical sleeve gastrectomy (VSG).

126 bute to variable outcomes following vertical sleeve gastrectomy (VSG).

127 ad portomesenteric vein thrombosis, 16 after sleeve gastrectomy and 1 following adjustable gastric ba

128 compared with 19% in patients who underwent sleeve gastrectomy and 16% following gastric banding (P<

129 ch) and 98% laparoscopic (n = 162,969; 69.8% sleeve gastrectomy and 27.8% gastric bypass) in 2016.

130 r morbid obesity in the United States toward sleeve gastrectomy and away from the adjustable gastric

131 ter bariatric surgery (sleeve gastrectomy or sleeve gastrectomy and biliopancreatic diversion with du

132 2 most common procedures used currently, the sleeve gastrectomy and gastric bypass, have similar effe

133 dergone Roux-en-Y gastric bypass or vertical sleeve gastrectomy and had persistent or recurrent type

134 Of the bariatric surgery models, sleeve gastrectomy and mRYGB had higher success rates an

135 rthermore, we showed that bariatric surgery (sleeve gastrectomy and proximal and distal RYGB) dynamic

136 All primary, laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass procedur

137 ome patients with CKD are not candidates for sleeve gastrectomy and the incremental increased-risk fr

138 ness, safety, and durability of laparoscopic sleeve gastrectomy as a definitive therapeutic option fo

139 in the timing of payers' decisions to cover sleeve gastrectomy as a natural experiment.

140 Despite sleeve gastrectomy becoming the most common surgical wei

141 -Y gastric bypass or a laparoscopic vertical sleeve gastrectomy between 2007 and 2009 (n = 4088) with

142 CKD patients who underwent RYGB or sleeve gastrectomy between 2015 and 2017 were identified

143 s for surgical skill varied for laparoscopic sleeve gastrectomy but did not have a significant impact

144 Laparoscopic sleeve gastrectomy did not reliably relieve or improve G

145 djustable gastric banding, and most recently sleeve gastrectomy for both significant weight loss and

146 Gastric bypass was found to be superior to sleeve gastrectomy for remission of type 2 diabetes at 1

147 gher in the gastric bypass group than in the sleeve gastrectomy group (risk difference 27% [95% CI 10

148 Gastric emptying was accelerated in the sleeve gastrectomy group compared with the other 2 group

149 In the sleeve gastrectomy group, eight of 55 participants had e

150 significant larger than in the nonobese and sleeve gastrectomy groups.

151 rge cohort of commercially insured patients, sleeve gastrectomy had a superior safety profile to gast

152 At 2 years from surgery, patients undergoing sleeve gastrectomy had fewer re-interventions (sleeve 9.

153 l responses in morbidly obese patients after sleeve gastrectomy has not been determined.

154 Sleeve gastrectomy has rapidly become the most common ba

155 Gastric bypass and sleeve gastrectomy have a greater effect than gastric ba

156 cal therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy in 150 obese patients with uncontroll

157 ght loss procedure such as gastric bypass or sleeve gastrectomy in a single procedure.

158 We performed a novel sleeve gastrectomy in rats that resects approximately 80

159 duled to undergo Roux-en-Y gastric bypass or sleeve gastrectomy in three bariatric centers in the Net

160 Finally, complications after sleeve gastrectomy include postoperative leaks and stric

161 ombined robot-assisted kidney transplant and sleeve gastrectomy is feasible in morbidly obese patient

162 patients who qualify for bariatric surgery, sleeve gastrectomy is often preferred to RYGB based on p

163 urgery and, in particular, gastric bypass or sleeve gastrectomy may be considered as new treatment op

164 However, the higher risk of revisions in sleeve gastrectomy merits further exploration.

165 09 patients (Roux-en-Y gastric bypass n=465; sleeve gastrectomy n=44) could be matched 1:1 to a contr

166 The objective was to assess the effects of sleeve gastrectomy on hunger, satiation, gastric and gal

167 efore and 8-12 days after bariatric surgery (sleeve gastrectomy or sleeve gastrectomy and biliopancre

168 ients were 1:1 propensity-score matched with sleeve gastrectomy patients based on preoperative factor

169 Among the surgical cohort, sleeve gastrectomy patients had a higher risk of develop

170 Sleeve gastrectomy patients showed the lowest ghrelin co

171 morbidly obese and nonobese groups; however, sleeve gastrectomy patients were less hungry and more sa

172 Among well-matched cohorts of RYGB and sleeve gastrectomy patients, incidence of primary outcom

173 utcomes for gastric bypass, gastric band, or sleeve gastrectomy performed on patients with a body mas

174 patients if they had a laparoscopic vertical sleeve gastrectomy procedure and a higher BMI at surgery

175 surgery between 2012 and 2016, the share of sleeve gastrectomy rose from 52.6% (2012) to 75% (2016).

176 Sleeve gastrectomy seems to be associated with profound

177 The banded versus nonbanded sleeve gastrectomy single-center, randomized controlled

178 ective cohorts, 5 retrospective cohorts) and sleeve gastrectomy studies (2 retrospective cohorts) had

179 mark, revisions were slightly more common in sleeve gastrectomy than in gastric bypass (sleeve 0.6%,

180 Prior studies comparing sleeve gastrectomy to gastric bypass are limited by low

181 ally rich, bariatric-specific data comparing sleeve gastrectomy to the adjustable gastric band, and t

182 easured confounding, we use the prior year's sleeve gastrectomy utilization within each state as an i

183 type 2 diabetes mellitus undergoing vertical sleeve gastrectomy was also recruited (n = 12) as a comp

184 abolic surgery (Roux-en-Y gastric bypass and sleeve gastrectomy) and major adverse cardiovascular eve

185 bariatric procedure (eg, a gastric bypass or sleeve gastrectomy).

186 ures, which included 74% gastric bypass, 15% sleeve gastrectomy, 10% adjustable gastric banding, and

187 ional study of 12 patients who had undergone sleeve gastrectomy, 12 patients who had undergone RYGB,

188 Of 64,537 patients, 46% underwent sleeve gastrectomy, 22% revisited the emergency departme

189 ) of laparoscopic adjustable gastric band, 0 sleeve gastrectomy, and 0.14% (95% CI, 0.08%-0.25%) of t

190 astric bypass, 56% of patients who underwent sleeve gastrectomy, and 50% of patients following gastri

191 aroscopic Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and adjustable gastric banding were

192 Surgical management (gastric banding, sleeve gastrectomy, and Roux-en Y gastric bypass) can pr

193 Patients who had a sleeve gastrectomy, gastric bypass, or duodenal switch w

194 ic bypass, n = 162; gastric banding, n = 32; sleeve gastrectomy, n = 23), a mean excess weight loss (

195 mon bariatric procedures, gastric bypass and sleeve gastrectomy, on remission of diabetes and beta-ce

196 surgery, including Roux-en-Y gastric bypass, sleeve gastrectomy, or adjustable gastric banding.

197 (gastric banding, Roux-en-Y gastric bypass, sleeve gastrectomy, or other/unknown).

198 uch as Roux-en-Y gastric bypass and vertical sleeve gastrectomy, produce significant and durable weig

199 after distinct bariatric procedures [i.e., a sleeve gastrectomy, proximal Roux-en Y gastric bypass (R

200 c surgery models, including gastric banding, sleeve gastrectomy, Roux-en-Y gastric bypass (RYGB), mod

201 ominal surgery, including bariatric surgery (sleeve gastrectomy, Roux-en-Y gastric bypass), colorecta

202 After vertical sleeve gastrectomy, the level of BA increased [total: 1.

203 cal therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy.

204 ne disease after Roux-en-Y gastric bypass or sleeve gastrectomy.

205 (95% CI, 22 to 30) among those who underwent sleeve gastrectomy.

206 ombined robot-assisted kidney transplant and sleeve gastrectomy.

207 stric banding, and 60% (95% CI, 51-70) after sleeve gastrectomy.

208 adjustable gastric banding, and laparoscopic sleeve gastrectomy.

209 male subjects aged 25 to 50 years undergoing sleeve gastrectomy.

210 cal therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy.

211 lower risk of all cardiovascular events than sleeve gastrectomy.

212 s postprandial GLP-1 and PYY increased after sleeve gastrectomy.

213 Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy.

214 opic gastric band placement, or laparoscopic sleeve gastrectomy.

215 e in both obese rodents and humans following sleeve-gastrectomy (SG).

216 was greater in the gastric-bypass group and sleeve-gastrectomy group (-29.4+/-9.0 kg and -25.1+/-8.5

217 ypass group (P<0.001), and 6.6+/-1.0% in the sleeve-gastrectomy group (P=0.003).

218 (P=0.002) and 37% (18 of 49 patients) in the sleeve-gastrectomy group (P=0.008).

219 pass group (P<0.001) and 24% of those in the sleeve-gastrectomy group (P=0.01).

220 gastric-bypass group and 21.1+/-8.9% in the sleeve-gastrectomy group, as compared with a reduction o

221 baseline observed in the gastric-bypass and sleeve-gastrectomy groups were superior to the changes s

222 (-23%, -19%, and -5% in the gastric-bypass, sleeve-gastrectomy, and medical-therapy groups, respecti

223 The roles of complex muscle sleeve geometry and fiber orientation in the pulmonary v

224 s of oxidation as a result of the tight and "sleeved in" physical arrangement, rather than the chemic

225 tial characteristics was observed in the SVC sleeve, including action potentials with short and long

226 mouse small intestine, an everted intestinal sleeve incubated in a physiological Ringer's solution.

227 o the deposition capillary by the connection sleeve inside the matrix reservoir.

228 The sleeve is cut into segments of 2 mm in length, and then

229 The sleeve is easy-to-use, is completely resource independen

230 For the test, a non-removable tape sleeve is placed around the animal's paw and the time to

231 ake of liberated glucose into the intestinal sleeve is prevented by the transport inhibitor phlorizin

232 ence of hemorrhage and vascular basal lamina sleeves lacking endothelial cells.

233 PV muscle sleeves may develop voltage-independent Ca(i) release, r

234 Basement membrane sleeves may facilitate this transport.

235 re constrained by pulleys, connective tissue sleeves mechanically coupled to the orbital walls.

236 hm activation mapping revealed evidence of a sleeve of atrial muscle in the vein.

237 lar zones of both calyces together provide a sleeve of axons that ensheaths the two shafts.

238 e bacterial contamination (31% vs 7%) on the sleeve of surgical team members wearing cloth gowns than

239 Each chamber had a nylon cylinder encased by sleeves of aluminum and polycarbonate to simulate trabec

240 These results suggest that empty sleeves of basement membrane and accompanying pericytes

241 eated tumors and surprisingly coincided with sleeves of basement membrane left behind after pruning o

242 Empty sleeves of basement membrane were left behind.

243 hdrawal, endothelial sprouts grew into empty sleeves of basement membrane.

244 ctopic pacemaking activity in the myocardium sleeves of the pulmonary vein (PV) and systemic venous r

245 AX102 also increased the width of sleeves of viable tumor cells around blood vessels by 66

246 To quantify the influence of the sleeves on rod rigidity, we applied the worm-like chain

247 This secures the two sleeves on the shaft of the trocar, such that they act a

248 re randomized to MWM versus surgery (bypass, sleeve or band, based on patient preference).

249 tes by antibody HUIV26 did not eliminate the sleeves or slow revascularization.

250 gut called the cardia and forms a continuous sleeve (or sleeves) that is always present.

251 safe, and healthcare utilization benefits of sleeve over bypass are preserved across both Medicare el

252 Subjects wore the sleeve over the more painful OA knee for at least 12 hou

253 lab-scale UV reactor consisting of one lamp sleeve placed perpendicular to flow.

254 , namely: VSG, Fundal (F)-Resection, Gastric Sleeve Plication (GSP), Fundal-Plication, and Fundal-Con

255 hat the increase of postoperative GERD after sleeve (POGAS) was 19% and de novo reflux was 23%.

256 lectrophysiological properties of canine SVC sleeve preparations and the effect of ranolazine on late

257 However, emerging evidence suggests that the sleeve procedure is associated with fewer reoperations,

258 Those who wore the placebo sleeve reported a 9.7% decrease from baseline (P = 0.002

259 d correctly that they had received the verum sleeve reported a highly significant decrease in WOMAC p

260 ined from patients undergoing gastrectomy or sleeve resection or gastric antral organoids) were incub

261 ve that all patients should have a segmental sleeve resection to ensure clearance of transmural disea

262 sts regarding long-term outcomes for gastric sleeve resections.

263 Volunteers wearing long-sleeve shirts and pants produced 40% more FAPs relative

264 rature (25.1-32.6 degrees C), clothing (long-sleeved shirts/pants or T-shirts/shorts), age (teenagers

265 two membranes separate, leaving a cytosolic sleeve spanned by tethers whose presence correlates with

266 were randomized to 2 treatment groups: verum sleeve (specially fabricated to retain body heat) or pla

267 y fabricated to retain body heat) or placebo sleeve (standard cotton/elastane sleeve).

268 he 2 procedures (Swiss Multicentre Bypass Or Sleeve Study; SM-BOSS).

269 Sleeve sucrase activity is abolished by the inhibitor ca

270 Pulleys, consisting of collagen and elastin sleeves supported by connective tissue containing SM, we

271 GF-binding protein 2 (IGFBP-2) after gastric sleeve surgery in healthy obese individuals.

272 ay mediate the beneficial effects of gastric sleeve surgery in improving insulin sensitivity and redu

273 is performed transanally using an endorectal sleeve technique.

274 line were measured using an in vitro everted sleeve technique.

275 side a matrix reservoir through a connection sleeve that allows mixing of the LC effluent with an app

276 r-integrated, lightweight, textile-based arm sleeve that can recognize gestures without encumbering t

277 For example, the periosteum, a soft tissue sleeve that envelops all nonarticular bony surfaces of t

278 guration also eliminates the internal Nafion sleeve that is critical to operation for the standard bo

279 bariatric procedure involving an impermeable sleeve that is delivered endoscopically in the proximal

280 eases the potential flexibility of the rigid sleeve that surrounds the gamma subunit C-terminus also

281 the cardia and forms a continuous sleeve (or sleeves) that is always present.

282 s automaticity and triggered activity in SVC sleeves, thus generating extrasystolic activity capable

283 eline and after 4 weeks of wear, after which sleeve use was discontinued.

284 etrospective analyses suggest that banding a sleeve using a silicone ring may decrease weight regain

285 Ps) were recorded from superfused SVC and PV sleeves using microelectrode techniques.

286 Among the elderly (n = 8,510), sleeve was associated with lower 3-year complications (2

287 Among the disabled (n=21,595), sleeve was associated with lower 3-year mortality (2.1%

288 This sleeve was connected to a carbon dioxide source and dire

289 3-dimensional modeling techniques, a polymer sleeve was created and attached to an ESU pencil.

290 The fibrin sleeve was mechanically stripped off the shaft of the ca

291 The sleeve was tested with and without carbon dioxide (contr

292 After 4 weeks of sleeve wear, subjects in the active treatment group repo

293 Type IV collagen-immunoreactive sleeves were also present on endothelial sprouts, suppor

294 e electrophysiologic properties of canine PV sleeves were investigated using a combination of high-re

295 Indeed, pericyte sleeves were significantly longer than the CD31-immunore

296 thioacetals is that terephthalaldehyde (TAA) sleeves, which are too flexible in the case of acetals c

297 thelial cells led to empty basement membrane sleeves, which were visible at 7 days, but only 54% rema

298 We demonstrate the performance of the sleeve with human blood samples and compare it against c

299 nd avascular type IV collagen-positive empty sleeves with remaining pericytes.

300 d to the subject's impression of the type of sleeve worn.